ZLD1039
ZLD1039 is a potent, highly selective, and orally bioavailable EZH2 inhibitor. ZLD1039 shows potent and concentration-dependent inhibition of PRC2 enzymatic activity against EZH2 wild-type as well as Y641F, and A677G mutant enzymes with IC50 values of 5.6, 15, and 4.0 nM, respectively. ZLD1039 inhibits breast tumor growth and metastasis[1].
Product Specifications
CAS Number
[1826865-46-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zld1039.html
Purity
98.48
Solubility
10 mM in DMSO
Smiles
O=C(NCC1=C2CCCCC2=C(C)NC1=O)C3=CC(C4=CC=C(N5CCN(C)CC5)N=C4)=CC(N(CC)C6CCOCC6)=C3C
Molecular Formula
C36H48N6O3
Molecular Weight
612.80
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EZH2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MnTMPyP pentachloride (Manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin. 5Cl-)
MnTMPyP pentachloride (Manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin. 5Cl-)
MnTMPyP pentachloride (Manganese (III) tetrakis (1-methyl-4-pyridyl) porphyrin. 5Cl-)